Kura Oncology
Hunkar Gunes has extensive experience in regulatory affairs, particularly in the field of oncology. Hunkar has held multiple positions as a Director of Regulatory Affairs at Kura Oncology, Inc. starting in January 2023. Prior to that, they served as a Senior Global Program Regulatory Manager in Oncology at Novartis Institutes for BioMedical Research (NIBR) from April 2017 to April 2022. Before NIBR, Hunkar worked as a Global Program Regulatory Manager in Oncology at Novartis from December 2011 to April 2017.
Hunkar Gunes attended the Pharmacy Faculty at the University of Strasbourg from 2009 to 2011. During this time, they pursued a Master's degree in Drug sciences with a specialization in regulatory affairs.
This person is not in any teams
This person is not in any offices
Kura Oncology
20 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.